Josep Bou

697 total citations
20 papers, 571 citations indexed

About

Josep Bou is a scholar working on Physiology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Josep Bou has authored 20 papers receiving a total of 571 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 7 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Josep Bou's work include Asthma and respiratory diseases (4 papers), Migraine and Headache Studies (3 papers) and Ion channel regulation and function (3 papers). Josep Bou is often cited by papers focused on Asthma and respiratory diseases (4 papers), Migraine and Headache Studies (3 papers) and Ion channel regulation and function (3 papers). Josep Bou collaborates with scholars based in Spain, Italy and Germany. Josep Bou's co-authors include Jesús Llenas, Esteban Morcillo, Julio Cortijo, Jörge Beleta, R. Massingham, R.W. Gristwood, José Palacios, Teresa Domènech, Vittorio Bini and Philippe Le Corvoisier and has published in prestigious journals such as British Journal of Pharmacology, European Urology and European Journal of Pharmacology.

In The Last Decade

Josep Bou

19 papers receiving 538 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Josep Bou Spain 11 221 191 166 93 62 20 571
Subbarao Vemulapalli United States 17 219 1.0× 60 0.3× 211 1.3× 55 0.6× 34 0.5× 37 725
Kozo Yao Japan 14 172 0.8× 34 0.2× 127 0.8× 33 0.4× 41 0.7× 27 598
Jan Beneš Czechia 12 192 0.9× 72 0.4× 83 0.5× 123 1.3× 33 0.5× 40 814
Masashi Ukai Japan 14 129 0.6× 52 0.3× 97 0.6× 31 0.3× 18 0.3× 30 792
Takayoshi Isoda United States 12 439 2.0× 110 0.6× 501 3.0× 49 0.5× 116 1.9× 16 1.0k
Dung Thai United States 15 218 1.0× 67 0.4× 41 0.2× 31 0.3× 64 1.0× 35 708
Sandra L. Jimmo Canada 10 416 1.9× 48 0.3× 177 1.1× 39 0.4× 15 0.2× 13 670
Han-liang Zhou United States 8 296 1.3× 48 0.3× 174 1.0× 15 0.2× 15 0.2× 15 449
Takaharu Ono Japan 11 181 0.8× 44 0.2× 145 0.9× 37 0.4× 12 0.2× 35 511
Pierre Roubert France 17 239 1.1× 85 0.4× 257 1.5× 12 0.1× 15 0.2× 30 675

Countries citing papers authored by Josep Bou

Since Specialization
Citations

This map shows the geographic impact of Josep Bou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josep Bou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josep Bou more than expected).

Fields of papers citing papers by Josep Bou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josep Bou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josep Bou. The network helps show where Josep Bou may publish in the future.

Co-authorship network of co-authors of Josep Bou

This figure shows the co-authorship network connecting the top 25 collaborators of Josep Bou. A scholar is included among the top collaborators of Josep Bou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josep Bou. Josep Bou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lazzeri, Massimo, Alexander Haese, Alexandre de la Taille, et al.. (2013). Serum Isoform [−2]proPSA Derivatives Significantly Improve Prediction of Prostate Cancer at Initial Biopsy in a Total PSA Range of 2–10 ng/ml: A Multicentric European Study. European Urology. 63(6). 986–994. 166 indexed citations
2.
Tomás, J. Segarra, et al.. (2008). Calcificaciones prostáticas. Actas Urológicas Españolas. 32(7). 768–768.
3.
Bou, Josep, et al.. (2002). [Small renal mass. Diagnostic management].. PubMed. 54(6). 593–601. 1 indexed citations
4.
Bou, Josep, et al.. (2001). Vascular Effects of the New Anti-Migraine Agent Almotriptan on Human Cranial and Peripheral Arteries. Cephalalgia. 21(8). 804–812. 35 indexed citations
5.
Crespo, M., Armando Vega, Josep Bou, et al.. (2000). Synthesis and biological evaluation of 2,5-dihydropyrazolo[4,3-c]quinolin-3-ones, a novel series of PDE 4 inhibitors with low emetic potential and antiasthmatic properties. Bioorganic & Medicinal Chemistry Letters. 10(23). 2661–2664. 29 indexed citations
6.
Bou, Josep, et al.. (2000). Functional profile of almotriptan in animal models predictive of antimigraine activity. European Journal of Pharmacology. 410(1). 43–51. 23 indexed citations
7.
Bou, Josep, Teresa Domènech, Jaume Puig, et al.. (2000). Pharmacological characterization of almotriptan: an indolic 5-HT receptor agonist for the treatment of migraine. European Journal of Pharmacology. 410(1). 33–41. 31 indexed citations
8.
Cortijo, Julio, Miguel Martı́-Cabrera, Teresa Domènech, et al.. (1997). Characterization of 5‐HT receptors on human pulmonary artery and vein: functional and binding studies. British Journal of Pharmacology. 122(7). 1455–1463. 47 indexed citations
9.
Cortijo, Julio, Josep Bou, Jörge Beleta, et al.. (1993). Investigation into the role of phosphodiesterase IV in bronchorelaxation, including studies with human bronchus. British Journal of Pharmacology. 108(2). 562–568. 95 indexed citations
10.
Ortiz, J.L., Julio Cortijo, José Manuel González y Fernández Valles, Josep Bou, & Esteban Morcillo. (1993). Rolipram inhibits airway microvascular leakage induced by platelet-activating factor, histamine and bradykinin in guinea-pigs. Journal of Pharmacy and Pharmacology. 45(12). 1090–1092. 17 indexed citations
11.
Fernández, Andrés G., Jaume Puig, Jörge Beleta, et al.. (1992). Pancopride, a potent and long-acting 5-HT3 receptor antagonist, is orally effective against anticancer drug-evoked emesis. European Journal of Pharmacology. 222(2-3). 257–264. 6 indexed citations
12.
Gristwood, R.W., et al.. (1992). Studies on the cardiac actions of flosequinan in vitro. British Journal of Pharmacology. 105(4). 985–991. 23 indexed citations
13.
Cortijo, Julio, et al.. (1992). Rolipram inhibits PAF‐induced airway microvascular leakage in guinea‐pig: a comparison with milrinone and theophylline. Fundamental and Clinical Pharmacology. 6(6). 247–249. 18 indexed citations
14.
Bou, Josep, et al.. (1992). Cardiovascular Effects of LAS 30538, a New Vascular Selective Ca2+-Channel Blocker. Journal of Pharmacy and Pharmacology. 44(10). 830–835. 6 indexed citations
15.
Puig, Jaume, et al.. (1990). Pancopride: a novel 5-HT3 antagonist with potent antiemetic action. European Journal of Pharmacology. 183(4). 1214–1214. 3 indexed citations
16.
Bou, Josep & R. Massingham. (1986). Effect of diltiazem upon contractile responses to phenylephrine, cirazoline, Sgd 101/75, St 587 and B-HT 920 in rabbit aorta and dog saphenous vein preparations. European Journal of Pharmacology. 121(3). 319–325. 10 indexed citations
17.
Bou, Josep, et al.. (1986). Involvement of enteric neurones in the response of guinea‐pig ileum preparations to metoclopramide. British Journal of Pharmacology. 88(1). 95–102. 4 indexed citations
18.
Massingham, R., Josep Bou, & David J. Roberts. (1985). A COMPARISON OF THE STIMULATORY EFFECTS OF METOCLOPRAMIDE AND CINITAPRIDE IN THE GUINEA‐PIG ISOLATED ILEUM. Journal of Autonomic Pharmacology. 5(1). 41–53. 10 indexed citations
19.
Bou, Josep & R. Massingham. (1984). Phenoxybenzamine-induced inhibition of cirazoline pressor responses in pithed rats pretreated with organic or inorganic calcium entry blocking drugs. European Journal of Pharmacology. 102(3-4). 535–539. 4 indexed citations
20.
Bou, Josep, Jesús Llenas, & R. Massingham. (1983). CALCIUM ENTRY BLOCKING DRUGS, ‘CALCIUM ANTAGONISTS’ AND VASCULAR SMOOTH MUSCLE FUNCTION. Journal of Autonomic Pharmacology. 3(3). 219–232. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026